Search PubMed⌕ Search

Biomedical subjects

A R Johnson

Publications and source records attributed to A R Johnson.

At least 145 records · Page 8Linked to original sources
PubMed1975

Autoxidation in milk rich in linoleic acid. I. An objective method of measuring autoxidation and evaluating antioxidants.

Autoxidation was studied in milk obtained from cows fed on formaldehyde-treated casein-safflower oil supplement. The fat of this milk contained high levels of linoleic acid. A rapid disappearance of dissolved oxygen (DO), measured by using a oxygen electrode, from milk samples stored at 0 degrees C in tubes without head-space, coincided with the development of oxidized flavours detected organoleptically. A correlation coefficient of 0.9 with 69 degrees of freedom (P smaller than 0.001) was obtained between the amount of DO disappearing and the taste panel scores for oxidized flavours. Butylated hydroxyanisole, sesamol, nordihydroguaiaretic acid, ethoxyquin, or butylated hydroxyanisole with propylgallate or tocopherols, when added in emulsified form to the milk at the rate of 10-15 mg/l milk checked the development of oxidized flavours and the rapid disappearance of DO. Other antioxidants tested were either ineffective or imparted off-flavours to milk. Samples of mare's milk neither developed oxidized flavours nor showed rapid disappearance of DO over a test period of 8 d. The oxygen electrode provides a convenient and sensitive method for studying autoxidation and evaluating antioxidants in milk.

Animals↗
PubMed1975

The uptake of a substituted acridone by rat mast cells in relationship to histamine release: a possible indicator of exocytosis-induced expansion of the plasma membrane.

A substituted acridone, 10-(2-dimethylaminopropyl)-9-acridone HCl (M-129), was taken up by isolated rat peritoneal and pleural mast cells in direct relationship to the degree of selective histamine release induced by compound 48/80. Other selective releasing agents, i.e., polymyxin B and anti-rat mast cell serum, also augmented uptake of M-129. Augmented uptake of M-129 was inhibited by measures that inhibited selective histamine release, i.e., cold, brief heating of the mast cells, N-ethylmaleimide and ninhydrin. 48/80 did not agument uptake of M-129 in rat erythrocytes or in rat serous fluid cells from which mast cells had been removed. M-129 taken up by mast cells was readily removed by two to three washes. Augmented uptake induced by 48/80 was specific for M-129 and acridone itself. Related compounds, i.e., a quaternary acridone derivative [10-(2-triethylaminoethyl)-9-acridone iodide] (M-231), acridine and acridan did not show augmented uptake. There was no relationship between heptane-water partition coefficients and uptake. It is postulated, based on estimates of cell membrane area, that M-129 is loosely bound to plasma membrane and that the augmented uptake associated with selective histamine release from rat mast cells is due to expanded plasma membrane that results from irreversible or slowly reversible exocytosis.

Acridines↗
PubMed1975

Release of histamine from rat mast cells by the complement peptides C3a and C5a.

Suspensions of rat mast cells were used to study the histamine-releasing actions of anaphylatoxins C3A and C5a in vitro. The peptides, derived from human or porcine complement proteins C3 and C5, were less potent than 48/80 but more potent than bradykinin in stimulating release of histamine from mast cells. The pattern of release resembled that of the anaphylactic release action, e.g. release was limited to less than 30 per cent of the cell histamine, the reaction was calcium-dependent and was potentiated by phosphatidyl serine. When C3a and C5a were added together to mast cell suspensions, the amount of histamine released was additive. Similarly, release by either peptide combined with bradykinin was additive. Histamine-releasing activity (as well as smooth muscle-stimulating activity) was abolished when the peptides were treated with pancreatic carboxy-peptidase B. Active or inactive peptides were bound by mast cells and addition of active C3a in combination with the inactive, des-arginine derivative, C3ai, resulted in partial inhibition of histamine release.

Anaphylaxis↗